Cookson Peirce & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Cookson Peirce & Co's BMY Position: Q3 2026 in Review
Cookson Peirce & Co increased its Bristol-Myers Squibb (BMY) stake by 39% in Q3 2026, buying an estimated $246K and bringing the position to 13,837 shares worth $863K. The position accounts for 0.03% of the portfolio, ranked #217.
Cookson Peirce & Co first reported a position in BMY in Q2 2013 and has held it in 13 quarters since. The position peaked at $8.74M in Q4 2022. 2,533 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Cookson Peirce & Co held 13,837 shares of Bristol-Myers Squibb worth $863K as of Q3 2026.
- Cookson Peirce & Co bought 3,894 Bristol-Myers Squibb shares in Q3 2026, an estimated $246K.
- Bristol-Myers Squibb made up 0.03% of Cookson Peirce & Co's portfolio in Q3 2026, its #217 holding.
- Cookson Peirce & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 13 quarters since.
- Cookson Peirce & Co's Bristol-Myers Squibb position peaked at $8.74M in Q4 2022.
- 2,533 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Cookson Peirce & Co's 13F filing for Q3 2026, filed 30 Oct 2026.